Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. Samsung Biologics Co.,Ltd.
  6. News
  7. Summary
    A207940   KR7207940008

SAMSUNG BIOLOGICS CO.,LTD.

(A207940)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about SAMSUNG BIOLOGICS CO.,LTD.
05/23SAMSUNG BIOLOGICS : Decision on Acquisition of Tangible Assets
PU
05/16Samsung Biologics Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 3..
CI
04/29SAMSUNG BIOLOGICS : Decision on Acquisition of Tangible Assets
PU
04/28Samsung Biologics' Net Income Surges 141% in March Quarter
MT
04/27SAMSUNG BIOLOGICS : Material Business Matters Related to Investment Decisions
PU
04/21SAMSUNG BIOLOGICS : Results of issuance (Voluntary Disclosure)
PU
04/05Allakos Inc. Enters into A Master Development Services Agreement with Samsung Biologics..
CI
04/01Samsung C&T - Samsung Life Science Fund makes first investment in US biotech firm Jagua..
AQ
03/30SAMSUNG BIOLOGICS : Decision on Acquisition of Tangible Assets
PU
03/30SAMSUNG BIOLOGICS : Conclusion of Single SalesContract or Supply Contract
PU
03/03SAMSUNG BIOLOGICS : Submission of Audit Report
PU
03/03SAMSUNG BIOLOGICS : Issuing Price of New Shares Issued by Paid-in Capital Increase
PU
03/02Samsung Biologics Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31..
CI
03/01Samsung Bioepis Secures 10 Biosimilar Products over 10 Years
MT
01/27Samsung Biologics to Buy Biogen's Stake in JV
DJ
More most relevant news
All news about SAMSUNG BIOLOGICS CO.,LTD.
05/23SAMSUNG BIOLOGICS : Decision on Acquisition of Tangible Assets
PU
05/16South Korea’s Leading Index Kospi Slips on Fears over Rate Hikes Across Economies..
MT
05/16Samsung Biologics Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 3..
CI
04/29SAMSUNG BIOLOGICS : Decision on Acquisition of Tangible Assets
PU
04/28South Korea’s Kospi Adds 1% on Stellar Q1 Earnings; Samsung Biologics Adds 3%
MT
04/28Samsung Biologics' Net Income Surges 141% in March Quarter
MT
04/28Samsung Biologics Completes Full Acquisition Of Samsung Bioepis
AQ
04/27SAMSUNG BIOLOGICS : Material Business Matters Related to Investment Decisions
PU
04/21SAMSUNG BIOLOGICS : Results of issuance (Voluntary Disclosure)
PU
04/05Allakos Inc. Enters into A Master Development Services Agreement with Samsung Biologics..
CI
More news
News in other languages on SAMSUNG BIOLOGICS CO.,LTD.
05/16L'indice phare de la Corée du Sud, le Kospi, chute en raison des craintes de hausses de..
05/16Samsung Biologics Co.,Ltd. annonce ses résultats pour le premier trimestre se terminant..
05/09Création d'un SPAC dédié à la fabrication des produits biopharmaceutiques à Paris
05/09Création d'un SPAC dédié à la fabrication des produits biopharmaceutiques à Paris
05/09Se crea la primera SPAC europea centrada en la producción de medicamentos complejos
04/28Le Kospi sud-coréen gagne 1 % grâce aux excellents résultats du premier trimestre ; Sam..
04/28Le bénéfice net de Samsung Biologics bondit de 141 % au trimestre de mars
04/05Allakos Inc. conclut un accord-cadre de services de développement avec Samsung Biologic..
03/24Le Kospi de la Corée du Sud chute en raison de la hausse des coûts de l'énergie et des ..
03/23Moderna, le fabricant de vaccins COVID, affiche son ambition pour le Japon en sponsoris..
More news
Analyst Recommendations on SAMSUNG BIOLOGICS CO.,LTD.
2020Samsung leader Jay Y. Lee indicted in South Korea on allegations linked to 2015 merger
RE
2020REFILE-UPDATE 3-Samsung leader Jay Y. Lee indicted in S.Korea on allegations linked to ..
RE
More recommendations
Press releases
05/23SAMSUNG BIOLOGICS : Decision on Acquisition of Tangible Assets
PU
04/29SAMSUNG BIOLOGICS : Decision on Acquisition of Tangible Assets
PU
04/28Samsung Biologics Completes Full Acquisition Of Samsung Bioepis
AQ
04/27SAMSUNG BIOLOGICS : Material Business Matters Related to Investment Decisions
PU
04/21SAMSUNG BIOLOGICS : Results of issuance (Voluntary Disclosure)
PU
More press releases
Analysis
COVID vaccine maker Moderna flags Japan ambition with sumo sponsorship
Upcoming event on SAMSUNG BIOLOGICS CO.,LTD.
08/16/22Interim 2022 Earnings Release (Projected)
Upcoming sector events
07/26/22BIOGEN INC. : Interim 2022 Earnings Release (Projected)
08/17/22CSL LIMITED : FY 2022 Earnings Release
08/22/22WUXI BIOLOGICS (CAYMAN) INC. : Interim 2022 Earnings Release (Projected)
10/25/22BIOGEN INC. : Q3 2022 Earnings Release (Projected)
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Biopharmaceuticals